EUVIMEDSkopri EUVIMED
Open access · CC BY-NC-ND 4.0

Immunoreactivity of canine, feline, and equine D-dimer with antibodies to human D-dimer

Juliet E Brown iD, Amir H Noormohammadi, Natalie F Courtman

Journal of Veterinary Internal Medicine · 2024-01-01 · 38 (1) · 187-196

DOI: 10.1111/jvim.16888 ↗

At a glance

Journal article in Journal of Veterinary Internal Medicine, published online on 2024-01-01. Written by Juliet E Brown and 2 co-authors. Institution: Faculty of Veterinary and Agricultural Sciences, University of Melbourne, Melbourne, Victoria, Australia. Major MEDLINE topics: Fibrin Fibrinogen Degradation Products, Antibodies, Monoclonal. Cited 3 times so far (Crossref); 42 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: American Society for Veterinary Clinical Pathology, EveryCat Health Foundation, University of Melbourne.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background

Commercially available D-dimer assays use antibodies against human D-dimer, with limited sensitivity and specificity data in companion animals.

Objectives

To evaluate the immunoreactivity of D-dimer in plasma of dogs, horses, and cats with commercially available antibodies to human D-dimer. Animals Plasma samples were collected from healthy dogs and horses, and from surplus feline plasma submitted for diagnostic purposes.

Methods

Descriptive research study. A cross-linked fibrin lysate was prepared from plasma samples, and SDS-PAGE and immunoblotting were performed with a variety of commercially available antibodies to human D-dimer.

Results

The selected antibodies demonstrated variable reactivity with D-dimer of each species. The monoclonal antibody DD44 bound canine D-dimer with good specificity and sensitivity, but this antibody did not react with feline or equine D-dimer. The polyclonal antibody D2D bound putative D-dimer in dogs, cats, and horses with good specificity, and higher sensitivity compared to human D-dimer. Conclusions and Clinical Importance The variable performance of commercially available human D-dimer assays between species is, in part, because of inter-species variation in D-dimer immunoreactivity. The use of these assays should follow validation studies. Monoclonal antibody DD44 could be a focus for the development of a canine-specific assay.

Subjects

MeSH terms (MEDLINE)

Fibrin Fibrinogen Degradation ProductsAntibodies, MonoclonalHumansCatsAnimalsDogsHorsesPlasmaSensitivity and Specificity

Author keywords

antibodiesfibrinolysisimmunoblottingthrombosisvalidation

Substances

fibrin fragment DFibrin Fibrinogen Degradation ProductsAntibodies, Monoclonal

Authors and institutions

  • Faculty of Veterinary and Agricultural Sciences, University of Melbourne, Melbourne, Victoria, Australia.

ORCID profiles: Juliet E Brown

Funding

  • American Society for Veterinary Clinical Pathology
  • EveryCat Health Foundation
  • University of Melbourne

Cite

APA

Brown, J. E., Noormohammadi, A. H., & Courtman, N. F. (2024). Immunoreactivity of canine, feline, and equine D-dimer with antibodies to human D-dimer. Journal of Veterinary Internal Medicine, 38(1), 187-196. https://doi.org/10.1111/jvim.16888

Vancouver

Brown JE, Noormohammadi AH, Courtman NF. Immunoreactivity of canine, feline, and equine D-dimer with antibodies to human D-dimer. Journal of Veterinary Internal Medicine. 2024;38(1):187-196. doi:10.1111/jvim.16888

BibTeX
@article{Brown2024,
  author = {Brown, Juliet E and Noormohammadi, Amir H and Courtman, Natalie F},
  title = {Immunoreactivity of canine, feline, and equine D-dimer with antibodies to human D-dimer},
  journal = {Journal of Veterinary Internal Medicine},
  year = {2024},
  volume = {38},
  number = {1},
  pages = {187--196},
  doi = {10.1111/jvim.16888}
}
Start for free →